mercoledì, 25 novembre 2020
18 Gennaio 2019

Revised guideline aims to strengthen global approach to development of new antibacterial medicines

January 14, 2019 – EMA has published a revision of its guideline on the evaluation of human medicines indicated for the treatment of bacterial infections for a six-month public consultation. Stakeholders can send their comments by 31 July 2019 to using the template provided. EMA plays an important role in the fight against antimicrobial resistance by supporting the development of new medicines and treatment approaches … (leggi tutto)